Page 25 of 39 · 913 questions tagged clinical-trials.
Numbers first: 8 mg · retatrutide. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Setup, so nobody has to ask: SURPASS-2 · mazdutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
For reference: SURPASS-3 · 5 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
The case in front of me: STEP 3 · oral semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Conditions: semaglutide · 30 °C. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and monographs without…
The case in front of me: REDEFINE-1 · oral semaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
For reference: REDEFINE-1 · nausea · 30 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
For reference: ATTAIN-1 · early satiety. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
Details up front: SUSTAIN-6 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Stated plainly: orforglipron · REDEFINE-1. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather…
Numbers first: SURMOUNT-OSA · nausea. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Setup, so nobody has to ask: SUSTAIN-6 · cagrilintide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have…
What I have: TRIUMPH-3 · orforglipron. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
I have three data points across nine months, which I hope is enough to see a trend. I can do the algebra. I am not confident about the conversion factors. If there is…
The case in front of me: STEP 1 · tirzepatide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
Details up front: cagrilintide · semaglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
For reference: PIONEER-1 · headache · 2 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
For reference: STEP 2 · hair thinning · 8 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
I have been on a stable schedule for eleven weeks, so this is not a first-week question. I have the document in front of me and I can read the numbers. What I cannot…
Concretely: TRIUMPH-1 · vomiting. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which…
What I am working with: ATTAIN-1 · cagrilintide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
The specifics, since they change the answer: dizziness · survodutide · SURPASS-2. I have the document in front of me and I can read the numbers. What I cannot do is…
What I have: cagrilintide · SURMOUNT-4. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. Please show the division. I want to check my own against yours. I…